These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34721290)

  • 1. Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion.
    Zhao L; Bi S; Fu J; Qi L; Li L; Fu Y
    Front Endocrinol (Lausanne); 2021; 12():717630. PubMed ID: 34721290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
    Mu F; Wang M; Huang J; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():29-35. PubMed ID: 37276726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux Results in Similar Pregnancy Outcomes with Lower Adverse Reaction Rates Compared to Low Molecular Weight Heparin in Chinese Recurrent Miscarriage Women.
    Liu C; Ma C; Hao Y
    Tohoku J Exp Med; 2024 Mar; 262(2):125-131. PubMed ID: 38057118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.
    Bai W; Zhang X; Sun S; Wang Q; Li C; Zhang X; Zhao A
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):683. PubMed ID: 34620101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
    Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
    Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
    Chakraborty P; Banerjee S; Saha P; Nandi SS; Sharma S; Goswami SK; Chakravarty B; Kabir SN
    PLoS One; 2013; 8(9):e74155. PubMed ID: 24040195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of low-molecular-weight heparin in altering uterine artery blood flow in recurrent spontaneous abortion: a prospective study.
    Zhang K; Wang E; Li Y; Xu H; Zhang J; Wang X; Shu J
    J Int Med Res; 2020 Aug; 48(8):300060520945558. PubMed ID: 32780610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic state of patients with unexplained recurrent spontaneous abortion.
    Lu X; Liu Z; Zhang X; Kang X; Shen W; Zhao A
    Int J Gynaecol Obstet; 2015 Nov; 131(2):161-5. PubMed ID: 26296564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
    Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E
    Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis.
    Jiang F; Hu X; Jiang K; Pi H; He Q; Chen X
    Taiwan J Obstet Gynecol; 2021 Jan; 60(1):1-8. PubMed ID: 33494980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective use of fondaparinux in patient with unresponsiveness to nadroparin.
    Hartinger JM; Svobodová A; Malíková I; Šachl R; Slanař O
    J Clin Pharm Ther; 2021 Apr; 46(2):539-542. PubMed ID: 33277918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative Bleeding in Patients With Acute Coronary Syndrome Treated With Fondaparinux Versus Low-Molecular-Weight Heparin Before Coronary Artery Bypass Grafting.
    Khodabandeh S; Biancari F; Kinnunen EM; Mariscalco G; Airaksinen J; Gherli R; Gatti G; Demal T; Onorati F; Faggian G; De Feo M; Santarpino G; Rubino AS; Maselli D; Salsano A; Nicolini F; Zanobini M; Ruggieri VG; Bounader K; Perrotti A; Dalén M
    Am J Cardiol; 2019 Feb; 123(4):565-570. PubMed ID: 30527774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
    Szummer K; Oldgren J; Lindhagen L; Carrero JJ; Evans M; Spaak J; Edfors R; Jacobson SH; Andell P; Wallentin L; Jernberg T
    JAMA; 2015 Feb; 313(7):707-16. PubMed ID: 25688782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
    Li XY; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.